Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure –A clinical practice Guideline Level 3
ddc:610
Extracorporeal Circulation
610 Medizin
610
Shock
Extracorporeal life support (ECLS)
Original Articles
Guideline
Recommendation
Extracorporeal membrane oxygenation (ECMO)
3. Good health
03 medical and health sciences
Extracorporeal Membrane Oxygenation
0302 clinical medicine
REFRACTORY CARDIOGENIC-SHOCK; MEMBRANE-OXYGENATION; LIFE-SUPPORT; POSITION PAPER; ADULT PATIENTS; CARDIOPULMONARY-RESUSCITATION; NEUROLOGIC COMPLICATIONS; SURVIVAL; ORGANIZATION; ARREST; Extracorporeal life support (ECLS); Extracorporeal membrane oxygenation (ECMO); Cardiac and circulatory failure; Guideline; Recommendation
RC666-701
Germany
Practice Guidelines as Topic
Diseases of the circulatory (Cardiovascular) system
Humans
Cardiac and circulatory failure
DOI:
10.1002/ehf2.13718
Publication Date:
2021-11-23T03:12:23Z
AUTHORS (44)
ABSTRACT
AbstractAims Worldwide applications of extracorporeal circulation for mechanical support in cardiac and circulatory failure, which are referred to as extracorporeal life support (ECLS) or veno‐arterial extracorporeal membrane oxygenation (va‐ECMO), have dramatically increased over the past decade. In spite of the expanding use and the immense medical as well as socio‐economic impact of this therapeutic approach, there has been a lack of interdisciplinary recommendations considering the best available evidence for ECLS treatment.Methods and Results In a multiprofessional, interdisciplinary scientific effort of all scientific societies involved in the treatment of patients with acute cardiac and circulatory failure, the first evidence‐ and expert consensus‐based guideline (level S3) on ECLS/ECMO therapy was developed in a structured approach under regulations of the AWMF (Association of the Scientific Medical Societies in Germany) and under use of GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria. This article presents all recommendations created by the expert panel, addressing a multitude of aspects for ECLS initiation, continuation, weaning and aftercare as well as structural and personnel requirements.Conclusions This first evidence‐ and expert consensus‐based guideline (level S3) on ECLS/ECMO therapy should be used to apply the best available care nationwide. Beyond clinical practice advice, remaining important research aspects for future scientific efforts are formulated.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (76)
CITATIONS (32)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....